|Articles|September 12, 2022
Why eConsent Primes Studies & Patients for Success
Author(s)Medable
According to a survey conducted by Florence Healthcare, 47% of research sites had adopted eConsent by December 2020, just 8 months after the WHO declared an official pandemic. By July 2021, 75% of research sites had either used it or were looking into it. In conclusion - a decentralized consent process is here to stay. Learn why Medable's Total eConsent offering is the industry-leading remote consent technology, and how it can reduce your enrolment timelines by 50%.
Trending on PharmExec
1
The Current Status of the 340B Program
2
What 40 Conversations About a Pandemic Taught Me About How Pharma Communicates
3
Executive Order Cuts Recommended Childhood Vaccines Down to 11: Report
4
Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors
5